Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

RedHill Biopharma Announces First Patient Dosed in the Open-Label Extension Study to the Phase III S

b3cnewswireMarch 22, 2017

Tag: RedHill , Crohn’s disease

PharmaSources Customer Service